Conference attendance: Meet Inceptua Early Access & Unlicensed Medicines 2024
Meet Inceptua Early Access
& Unlicensed Medicines 2024
- Immuno-Oncology 360°, US, NY, February 27-29
- World EPA, Amsterdam, March 12-13
- Operationalize EAP, US, Boston March 19-21
- Glioblastoma Drug Development Summit, US, Boston, March 26-28
- WODC US, Boston, April 23-25
- European Conference on Rare Disease (ECRD ) 2024, Brussels, May 15-16
- ASCO 2024, Chicago May 31- June 4
- Bio International Convention, June 3-6
- EASL Congress, Milan, June 3-6
- DIA USA, San Diego June 16-20
- IASLC 2024 World Conference on Lung Cancer, San Diego, September 7-10
- BioHK 2024, Hong Kong, September 11-14
- ESMO 2024, Barcelona, September 13-17
- Operationalize EAP (Europe), London October
- WODC Europe, Barcelona, October 22-25
- Bio Europe 2024, Stockholm November 4-6
- SITC US, Houston, November 6-10
- ESMO Asia Congress, Singapore December 1-4
- ASH US, San Diego December 9+10
“Effectively Collect Real World Evidence for Early Access Programs”. We have asked Stuart a few questions to reflect on the topic …
Conference attendance: Meet Inceptua Clinical Trial Supply & Services in 2024